Capecitabine in Combination With Oxaliplatin and Bevacizumab (AXELOX) as 1st Line Treatment for Fit and Vulnerable Elderly Patients (Aged >70 Years) With Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-14-277
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Nab-Paclitaxel as Second-Line Treatment in Advanced Gastric Cancer: A Multicenter Phase II Study of the Hellenic Oncology Research Group

Annals of Gastroenterology
2017English

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2011English

A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-Line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Multicenter Phase II Study of Docetaxel Plus Oxaliplatin Combination Chemotherapy in Patients With Advanced Gastric Cancer: Daegu Gyeongbuk Oncology Group

British Journal of Cancer
Cancer ResearchOncology
2008English

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients With Recurrent or Metastatic Biliary Tract Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2018English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Second-Line Pazopanib in Patients With Relapsed and Refractory Small-Cell Lung Cancer: A Multicentre Phase II Study of the Hellenic Oncology Research Group

British Journal of Cancer
Cancer ResearchOncology
2017English

Capecitabine and Oxaliplatin in Combination as First- Or Second-Line Therapy for Metastatic Breast Cancer: A Wisconsin Oncology Network Trial

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy